These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33592195)

  • 1. Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies.
    Xiang Y; Sang Z; Bitton L; Xu J; Liu Y; Schneidman-Duhovny D; Shi Y
    Cell Syst; 2021 Mar; 12(3):220-234.e9. PubMed ID: 33592195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
    Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
    J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
    Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
    PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering.
    Verkhivker G
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Affinity Maturation Using Computational Methods: From an Initial Hit to Small-Scale Expression of Optimized Binders.
    Medagli B; Soler MA; De Zorzi R; Fortuna S
    Methods Mol Biol; 2023; 2552():333-359. PubMed ID: 36346602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.
    Vincke C; Loris R; Saerens D; Martinez-Rodriguez S; Muyldermans S; Conrath K
    J Biol Chem; 2009 Jan; 284(5):3273-3284. PubMed ID: 19010777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superimmunity by pan-sarbecovirus nanobodies.
    Xiang Y; Huang W; Liu H; Sang Z; Nambulli S; Tubiana J; Williams KL; Duprex WP; Schneidman-Duhovny D; Wilson IA; Taylor DJ; Shi Y
    Cell Rep; 2022 Jun; 39(13):111004. PubMed ID: 35738279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides in headlock--a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy.
    Braun MB; Traenkle B; Koch PA; Emele F; Weiss F; Poetz O; Stehle T; Rothbauer U
    Sci Rep; 2016 Jan; 6():19211. PubMed ID: 26791954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning.
    Gaiotto T; Hufton SE
    PLoS One; 2016; 11(10):e0164296. PubMed ID: 27741319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application Progress of the Single Domain Antibody in Medicine.
    Tang H; Gao Y; Han J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
    Ferrari D; Garrapa V; Locatelli M; Bolchi A
    Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
    Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2553. PubMed ID: 30524421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of epitope-targeting nanobody based on native protein-protein interactions for FtsZ filamentation suppressor.
    Nakazawa H; Katsuki T; Matsui T; Tsugita A; Yokoyama T; Ito T; Kawada S; Tanaka Y; Umetsu M
    Biotechnol J; 2023 Nov; 18(11):e2300039. PubMed ID: 37458140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of nanobodies with potential to reduce patients' IgE binding to Bet v 1.
    Zettl I; Ivanova T; Strobl MR; Weichwald C; Goryainova O; Khan E; Rutovskaya MV; Focke-Tejkl M; Drescher A; Bohle B; Flicker S; Tillib SV
    Allergy; 2022 Jun; 77(6):1751-1760. PubMed ID: 34837242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of a camelid derived antibody targeting a linear epitope in the hinge domain of human PCSK9 protein.
    Li X; Hong J; Gao X; Wang M; Yang N
    Sci Rep; 2022 Jul; 12(1):12211. PubMed ID: 35842473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobody(R)-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sites.
    Nguyen-Duc T; Peeters E; Muyldermans S; Charlier D; Hassanzadeh-Ghassabeh G
    Nucleic Acids Res; 2013 Mar; 41(5):e59. PubMed ID: 23275538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nanobody against urease activity of Helicobacter pylori.
    Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
    Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.